Madrigal Pharmaceuticals, Inc. (MDGL) Covered Calls

You can sell covered calls on Madrigal Pharmaceuticals, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MDGL (prices last updated Fri 4:16 PM ET):

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
288.58 -14.09 275.00 299.90 928K - 6.6
Covered Calls For Madrigal Pharmaceuticals, Inc. (MDGL)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Dec 20 290 17.60 282.30 2.7% 27.4%
Jan 17 290 26.60 273.30 6.1% 34.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company's lead candidate is MGL-3196, an orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) ß-selective agonist, which is in Phase II clinical trials for the treatment of non-alcoholic steatohepatitis and heterozygous familial hypercholesterolemia. It is also developing MGL-3745, a THR-ß-selective small molecule that is in preclinical trials. The company has research, development, and commercialization agreement with Hoffmann-La Roche to develop, use, sell, offer for sale, and import various licensed products. Madrigal Pharmaceuticals, Inc. was founded in 2011 and is headquartered in West Conshohocken, Pennsylvania.